Details for New Drug Application (NDA): 021918
✉ Email this page to a colleague
The generic ingredient in CETRAXAL is ciprofloxacin hydrochloride. There are thirty-four drug master file entries for this compound. Fifty-two suppliers are listed for this compound. Additional details are available on the ciprofloxacin hydrochloride profile page.
Summary for 021918
Tradename: | CETRAXAL |
Applicant: | Wraser Pharms |
Ingredient: | ciprofloxacin hydrochloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION/DROPS;OTIC | Strength | EQ 0.2% BASE | ||||
Approval Date: | May 1, 2009 | TE: | RLD: | Yes |
Complete Access Available with Subscription